APOE and Alzheimer disease: Since individuals with ApoE-4 carriers are at increased risk of developing MCI and AD [76], abnormalities in EEG-alpha oscillations elicited by the working-memory-related task could thus be considered a promising biomarker of MCI or early-onset AD.